U.S. Markets closed

Arena Pharmaceuticals, Inc. (ARNA)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
24.93+0.40 (+1.63%)
At close: 4:00PM EDT

24.93 0.00 (0.00%)
After hours: 4:35PM EDT

People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue123,97538,32636,970
Cost of Revenue15,34113,1757,759
Gross Profit108,63425,15129,211
Operating Expenses
Research Development66,42588,411100,347
Selling General and Administrative31,24335,96634,137
Non Recurring28,1123,9723,972
Total Operating Expenses---
Operating Income or Loss-17,146-103,198-105,273
Income from Continuing Operations
Total Other Income/Expenses Net7622,04751,680
Earnings Before Interest and Taxes-16,384-101,151-53,593
Interest Expense6,5126,8286,915
Income Before Tax-22,896-107,979-60,508
Income Tax Expense---
Minority Interest491491491
Net Income From Continuing Ops-22,516-107,979-60,508
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-22,516-107,979-60,508
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-22,516-107,979-60,508